Evrofarma SA (EVROF) — Financial Flexibility Index

Latest as of December 2022: 0.06x

Evrofarma SA (EVROF) has a Financial Flexibility Index of 0.06x as of December 2022. Free cash flow of €2.13 Million (operating CF €1.52 Million minus capex €615.00K) represents 0% of total liabilities (€34.79 Million). Check Evrofarma SA strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

0.06x
Free Cash Flow / Total Liabilities

Free Cash Flow

€2.13 Million
Operating CF − Capex

Total Liabilities

€34.79 Million
EUR

Capital Expenditures

€615.00K
EUR

Evrofarma SA Financial Flexibility Index (2014–2022)

Historical Financial Flexibility Index trend for Evrofarma SA across 9 annual periods. See Evrofarma SA current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Evrofarma SA (2014–2022)

Year-by-year free cash flow to debt coverage for Evrofarma SA. For the full company profile including market capitalisation, see EVROF company net worth.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2022 0.13x €4.49 Million €2.44 Million €34.79 Million ▲ +72.4%
2021 0.07x €2.54 Million €-805.00K €33.91 Million ▲ +6.1%
2020 0.07x €2.36 Million €1.46 Million €33.42 Million ▼ -21.9%
2019 0.09x €2.65 Million €1.78 Million €29.33 Million ▼ -5.4%
2018 0.10x €3.11 Million €2.29 Million €32.58 Million ▼ -16.1%
2017 0.11x €3.92 Million €3.11 Million €34.37 Million ▲ +185.5%
2016 0.04x €1.34 Million €1.08 Million €33.55 Million ▼ -27.5%
2015 0.06x €1.90 Million €1.39 Million €34.55 Million ▲ +42.0%
2014 0.04x €1.47 Million €866.00K €38.00 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities